AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Halaven 1mg Injection

Prescription Icon
Prescription Required

Marketer

Eisai Pharmaceuticals India Pvt Ltd

Salt Composition

Eribulin Mesylate (1mg)

Overview Halaven 1mg Injection

Eribulin mesylate 1mg injection is indicated for metastatic breast cancer treatment in adults. This therapy is reserved for patients whose disease has progressed following prior anticancer regimens. Eribulin mesylate may be administered as monotherapy or in combination with other approved agents under a physician's guidance. Dosage and frequency are determined individually based on patient response and disease characteristics, and must be precisely followed as prescribed. Discontinuing treatment prematurely or altering the dosage can lead to severe adverse reactions. While therapeutic benefits may not be immediately apparent, consistent adherence is vital unless directed otherwise by your oncologist. Commonly reported adverse effects include fatigue, alopecia, nausea, and bowel dysfunction. This medication can suppress bone marrow function, increasing infection risk; routine blood tests to monitor hematologic parameters, hepatic function, renal function, uric acid levels, and electrolytes are essential. Peripheral neuropathy, characterized by numbness, tingling, or paresthesia in the extremities, may occur and requires prompt medical attention if persistent or problematic. Prior to initiating therapy, inform your physician of any pre-existing cardiac, hepatic, or renal conditions, as well as concurrent medication use, including antibiotics. Numerous drug interactions are possible, necessitating comprehensive disclosure of all medications. This treatment is contraindicated during pregnancy and lactation; reliable contraception is mandatory for both partners throughout the treatment period.

Primary Ingredients of Halaven 1mg Injection

No information provided. Please provide the text you wish me to rephrase.

Uses of Halaven 1mg Injection

Breast cancer with distant spread

Major Benefits of Halaven 1mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Halaven 1mg Injection:

  • Anemia (low number of red blood cells)
  • Weakness
  • Hair loss
  • Nausea
  • Constipation
  • Decreased white blood cell count
  • Fatigue
  • Peripheral neuropathy (tingling and numbness of feet and hand)

How to use Halaven 1mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Halaven 1mg Injection works:

Eribulin mesylate 1mg injection is a chemotherapy agent. Its mechanism of action involves disrupting microtubule networks essential for cancer cell division and proliferation. This halts cancer cell growth and leads to their demise.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction of Halaven 1mg Injection with alcohol is undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Eribulin mesylate 1mg injection should not be administered to pregnant individuals due to confirmed risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the hazards. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Eribulin mesylate 1mg injection is contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Eribulin mesylate 1mg injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Eribulin mesylate 1mg injection requires careful administration in individuals with impaired renal function. Dosage modification of eribulin mesylate 1mg injection might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Eribulin mesylate 1mg injection requires careful administration in individuals with hepatic impairment. Dosage modification of eribulin mesylate 1mg injection may be necessary. Physician consultation is advised.

What if you forget to take Halaven 1mg Injection :

NA

Facts to Know About Halaven 1mg Injection

LabelValue
Chemical Category Halichondrin B analog
Developing Habits No.
Type of Therapy Cancer Drugs
Behavior Class Non-Taxane Microtubule Inhibitors

FAQs on Halaven 1mg Injection

Halaven 1mg Injection may cause hair loss, a side effect that can range in severity and may be reversible. Discuss any hair loss concerns with your doctor.
Halaven 1mg Injection is typically administered on days 1 and 8 of a 21-day treatment cycle. Treatment length is individualized, with the number of cycles determined by your doctor. Treatment may be delayed or the dose adjusted based on your blood test results.
A doctor or nurse will administer Halaven 1mg Injection intravenously over 2 to 5 minutes. Your dose, determined by your body surface area (calculated from your weight and height), may be adjusted based on your blood test results and other health factors. Following the injection, a saline flush will ensure complete delivery of the Halaven.
Halaven 1mg Injection carries serious risks. These include a dangerously low white blood cell count (neutropenia), increasing the risk of life-threatening infections. Numbness, tingling, or pain in the hands and feet (peripheral neuropathy) is also common, sometimes severe. Use during pregnancy may harm the baby.
Women of childbearing age must use reliable contraception for three months following Halaven 1mg Injection treatment. Halaven may cause severe birth defects; its use during pregnancy is strictly contraindicated unless deemed absolutely essential after a thorough risk assessment for both mother and child.
Handle Halaven 1mg Injection with care, avoiding contact with skin, eyes, mouth, or nose. Wear gloves, goggles, and protective clothing. In case of skin contact, wash thoroughly with soap and water. Flush eyes, mouth, or nose with water if exposed. Pregnant staff should not handle this medication.
Halaven 1mg Injection should be diluted with up to 100ml of 0.9% sodium chloride solution (not 5% dextrose) before administration. This must be given by a healthcare professional under the supervision of a physician experienced in administering cancer chemotherapy.
Halaven 1mg Injection
27,549
MRP 31,885
13% off